14-day Premium Trial Subscription Try For FreeTry Free

Latest Data & Signals Issued

Signal Type Signal Value Data
Score 0.000 86 days ( -214.92 % )
Last Price $0.0570 0 %
High/ Low $0.0570 - $0.0570 0%
Chg 7 Days N/A $0.0570 $0.0570
Chg 30 Days N/A $0.0570 $0.0570
Chg 12 mos 216.67 % $0.0180 $0.0570
Trend - 3 mos N/A Width: 0.00000000 %
Trend - 12 mos 174.51 % Width: 107.26 %
Pred. range - 3 mos $0.0570 - $0.0570 0 % - 0 %
Pred. range - 12 mos $0.0862 - $0.179 51.20 % - 213.38 %
Short MA avg 3 mos Sell Nov 30, -1 - N/A days
Long MA avg 3 mos Sell Nov 30, -1 - N/A days
Short/Long MA avg 3 mos Sell Nov 30, -1 - N/A days
Short MA avg 12 mos Buy Dec 20, 2023 - 68 days
Long MA avg 12 mos Buy Nov 21, 2023 - 88 days
Short/Long MA avg 12 mos Buy Nov 29, 2023 - 83 days
Pivot Short Sell Mar 27, 2024 - 2 days
Bollinger Sell Nov 30, -1 - N/A days
MACD N/A No Dates Stored For This Signal
Click to get the best stock tips daily for free!

About Rubius Therapeutics Inc.

Rubius Therapeutics. Rubius Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of red cell therapeutics (RCTs) for the treatment of patients with severe diseases. The company is developing RTX-240 and RTX-224 for the treatment of solid tumors cancer; and RTX-aAPC to treat cancers. It is also developing RTX-321 for the treatment of HPV-positive tumors; and RTX-T1D for treating type 1 diabetes. The company was incorporated in 201... RUBY Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT